P550 Characterisation of hospitalised patients with ulcerative colitis treated with tofacitinib in the OCTAVE clinical programme for up to 7.8 years

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalJournal of Crohn's and Colitis
DOIs
Publication statusPublished - 2023

Keywords

  • Tofacitinib
  • Medicine
  • Ulcerative colitis
  • Octave (electronics)
  • Placebo
  • Janus kinase inhibitor
  • Internal medicine
  • Gastroenterology
  • Surgery
  • Disease
  • Rheumatoid arthritis
  • Physics
  • Alternative medicine
  • Pathology
  • Optics

Cite this